Antimicrobial susceptibility patterns of V. cholerae isolates during 2004–2013 (% susceptible)
| Year of isolation (n) | TE n (%) | AM n (%) | CH n (%) | GM n (%) | NF n (%) | CO n (%) | FZ n (%) | NA n (%) | CE n (%) |
|---|---|---|---|---|---|---|---|---|---|
| 2004 (79) | 77 (97.5) | 53 (67.1) | 1 (0.01) | 78 (98.7) | 75 (94.9) | 7 (8.9) | 6 (7.6) | 3 (3.8) | 27 (34.2) |
| 2005 (49) | 42 (85.7) | 19 (38.8) | 0 (0) | 46 (93.9) | 45 (91.8) | 1 (2) | 4 (8.2) | 1 (2) | 26 (53.1) |
| 2006 (30) | 27 (90) | 15 (50) | 15 (50) | 30 (100) | 27 (90) | 4 (13.3) | 3 (10) | 2 (6.7) | 24 (80) |
| 2007 (69) | 68 (98.6) | 67 (97.1) | 69 (100) | 67 (97.1) | 68 (98.6) | 9 (13) | 12 (17.4) | 4 (5.8) | 68 (98.6) |
| 2008 (43) | 22 (51.2) | 34 (79.1) | 43 (100) | 42 (97.7) | 42 (97.7) | 6 (14) | 7 (16.3) | 0 (0) | 43 (100) |
| 2009 (71) | 59 (83) | 25 (35.2) | 71 (100) | 68 (95.8) | 69 (97.2) | 19 (26.8) | 18 (25.4) | 5 (7) | 68 (95.8) |
| 2010 (52) | 44 (84.6) | 24 (46.2) | 51 (98.1) | 52 (100) | 49 (94.2) | 14 (26.9) | 44 (84.6) | 3 (5.8) | 38 (73.1) |
| 2011 (22) | 22 (100) | 0 (0) | 20 (90.9) | 22 (100) | 22 (100) | 5 (22.8) | 8 (36.4) | 0 (0) | 22 (100) |
| 2012 (4) | 4 (100) | 0 (0) | 0 (0) | 4 (100) | 4 (100) | 0 (0) | 4 (100) | 0 (0) | 1 (25) |
| 2013 (20) | 19 (95) | 0 (0) | 4 (20) | 17 (85) | 18 (90) | 2 (10) | 3 (15) | 0 (0) | 5 (25) |
AM, ampicillin; CE, cefuroxime; CH, chloramphenicol; CO, trimethoprim-sulfamethoxazole; FZ, furazolidone; GM, gentamicin; NA, nalidixic acid; NF, norfloxacin; TE, tetracycline; V. cholerae, Vibrio cholerae.